| Indicators | Browse All

Oragenics, Inc. (OGEN)

Healthcare | Biotechnology | Lakewood Ranch, United States | NYSE American
0.57 USD -0.02 (-2.747%) ⇩ (July 13, 2026, 4 p.m. EDT)

Short-term:★☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 3:50 a.m. EDT

The immediate outlook is severely clouded by a massive capital raise that sent the stock tumbling, signaling desperate liquidity needs rather than organic growth. While the recent price action shows a slight, fragile bounce off the lows, the underlying business is in freefall, having lost nearly 99.99% of its value over the last nine years with five consecutive years of negative returns. The company is burning cash aggressively, reporting significant negative operating and free cash flows, while management continues to dilute shareholders through stock option grants. With no dividend history and a balance sheet showing substantial debt relative to its tiny market cap, there is no safety margin here. The statistical models offer no help, predicting only a negligible upward drift with low confidence. This is a speculative trap for capital preservation, not a vehicle for recovery.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.030536
AutoETS0.030538
MSTL0.050561
AutoTheta0.088282

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 39%
H-stat 0.82
Ljung-Box p 0.000
Jarque-Bera p 0.782
Excess Kurtosis -0.07
Attribute Value
Sector Healthcare
Debt to Equity Ratio 0.908
Market Cap 2,571,815
Forward P/E -0.05
Beta 1.25
Website https://www.oragenics.com

Info Dump

Attribute Value
52 Week Change -0.58156025
Address1 9,015 Town Center Parkway
Address2 Suite 143
All Time High 1,620,000.0
All Time Low 0.5
Ask 0.0
Ask Size 300
Average Daily Volume10 Day 35,350
Average Daily Volume3 Month 50,272
Average Volume 50,272
Average Volume10Days 35,350
Beta 1.252
Bid 0.5681
Bid Size 2,100
Book Value 1.413
City Lakewood Ranch
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.57
Current Ratio 5.727
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 0.5861
Day Low 0.57
Debt To Equity 0.908
Display Name Oragenics
Dividend Date 1,516,579,200
Earnings Timestamp End 1,754,942,400
Earnings Timestamp Start 1,754,596,800
Ebitda Margins 0.0
Enterprise Value -3,479,128
Eps Forward -10.8
Eps Trailing Twelve Months -4.95
Esg Populated 0
Exchange ASE
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 0.5944
Fifty Day Average Change -0.024399996
Fifty Day Average Change Percent -0.041049793
Fifty Two Week Change Percent -58.156025
Fifty Two Week High 1.49
Fifty Two Week High Change -0.92
Fifty Two Week High Change Percent -0.6174497
Fifty Two Week Low 0.5
Fifty Two Week Low Change 0.06999999
Fifty Two Week Low Change Percent 0.13999999
Fifty Two Week Range 0.5 - 1.49
Financial Currency USD
First Trade Date Milliseconds 1,077,719,400,000
Float Shares 4,424,876
Forward Eps -10.8
Forward P E -0.052777775
Free Cashflow -5,872,412
Full Exchange Name NYSE American
Full Time Employees 3
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Gross Profits -2,696,586
Has Pre Post Market Data 1
Held Percent Insiders 0.01929
Held Percent Institutions 0.05763
Implied Shares Outstanding 4,511,957
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Ir Website http://www.oragenics.com/?q=investors
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,748,908,800
Last Split Factor 1:30
Long Business Summary Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.
Long Name Oragenics, Inc.
Market us_market
Market Cap 2,571,815
Market State PRE
Max Age 86,400
Message Board Id finmb_774436
Most Recent Quarter 1,774,915,200
Net Income To Common -9,826,737
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 2,644,457
Open 0.588
Operating Cashflow -9,334,941
Operating Margins 0.0
Payout Ratio 0.0
Peg Ratio -8.96
Phone 813 286 7900
Pre Market Change 0.023299992
Pre Market Change Percent 3.9754295
Pre Market Price 0.6094
Pre Market Time 1,784,020,701
Previous Close 0.5861
Price Hint 4
Price To Book 0.40339702
Profit Margins 0.0
Quick Ratio 4.669
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.0161
Regular Market Change Percent -2.74697
Regular Market Day High 0.5861
Regular Market Day Low 0.57
Regular Market Day Range 0.57 - 0.5861
Regular Market Open 0.588
Regular Market Previous Close 0.5861
Regular Market Price 0.57
Regular Market Time 1,783,972,800
Regular Market Volume 9,568
Return On Assets -1.0555999
Return On Equity -3.11
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 4,511,957
Shares Percent Shares Out 0.1718
Shares Short 775,021
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 708,926
Short Name Oragenics Inc.
Short Percent Of Float 0.172
Short Ratio 14.85
Source Interval 15
State FL
Symbol OGEN
Total Cash 6,107,078
Total Cash Per Share 1.354
Total Debt 56,134
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -4.95
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 0.83665
Two Hundred Day Average Change -0.26665002
Two Hundred Day Average Change Percent -0.31871155
Type Disp Equity
Volume 9,568
Website https://www.oragenics.com
Zip 34,202